Results 111 to 120 of about 2,874 (159)

Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections. [PDF]

Front Cell Infect Microbiol
Sivori F, Francalancia M, Truglio M, Cavallo I, Pronesti C, Fabrizio G, Celesti I, Cazzani A, Furzi L, Pimpinelli F, Di Domenico EG.   +10 more
europepmc   +1 more source

Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis. [PDF]

Ther Drug Monit
Gatti M, Cojutti PG, Rinaldi M, Ambretti S, Giannella M, Viale P, Pea F.   +6 more
europepmc   +1 more source

Population pharmacokinetics of meropenem-vaborbactam in acutely ill hospitalized patients with various degrees of renal dysfunction including continuous renal replacement therapy. [PDF]

Antimicrob Agents Chemother
Reed G, Valadez A, Smith BJ, McCreary EK, Kline EG, Neely MN, Squires KM, Shields RK, Rhodes NJ.   +8 more
europepmc   +1 more source

Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing <i>Enterobacter cloacae</i>. [PDF]

Antibiotics (Basel)
Keck JM, Dare RK, Saccente M, Vyas KS, Thompson RN.   +4 more
europepmc   +1 more source

Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying <i>bla</i>_OXA-48. [PDF]

Microbiol Spectr
Mojica MF, Zeiser ET, Becka SA, Six DA, Moeck G, Bonomo RA, Papp-Wallace KM.   +6 more
europepmc   +1 more source

Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for Multidrug-Resistant Organisms: A Retrospective Cohort Study. [PDF]

Open Forum Infect Dis
Boettcher SR, Kenney RM, Everson NA, Mulugeta SG, Shallal AB, Suleyman G, Veve MP.   +6 more
europepmc   +1 more source

Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations. [PDF]

Antimicrob Agents Chemother
Sánchez-Peña L, Rodríguez-Pallares S, Aja-Macaya P, Blanco-Martín T, González-Pinto L, Pérez-Rodríguez G, Le Terrier C, Portillo-Calderón I, Recacha E, Riazzo C, Vázquez-Ucha JC, Beceiro A, Aracil B, Oteo-Iglesias J, Martínez-Martínez L, Poirel L, Bou G, Arca-Suárez J.   +17 more
europepmc   +1 more source